# Barinthus Biotherapeutics

**Canonical:** https://apis.io/providers/barinthus-biotherapeutics/  
**Website:** https://www.barinthusbio.com/  
**APIs profiled:** 0

Barinthus Biotherapeutics plc (Nasdaq: BRNS) is a clinical-stage biopharmaceutical company developing novel immunotherapies designed to guide and reprogram T cells to overcome autoimmunity, inflammatory disease, chronic viral infection, and cancer. Its lead SNAP-TI and SNAP-CI antigen-specific platforms and ChAdOx/MVA immunotherapeutic candidates power a five-program pipeline including VTP-1000 (celiac disease), VTP-300 (chronic hepatitis B), VTP-200 (high-risk HPV), VTP-850 (recurrent prostate cancer), and VTP-1100 (HPV-related cancer). The company was formed in 2021 through the merger of Oxford University spinout Vaccitech plc and NIH/Johns Hopkins spinout Avidea Technologies, and is headquartered in Germantown, Maryland with research facilities in the UK. It was surfaced as a portfolio company of Hongshan and added to the API Evangelist network. As a therapeutics company it publishes no public developer API, SDK, or agent surface.

## Kin Score — 7.1 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 7.1).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Barinthus Biotherapeutics Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Healthcare, Biotechnology, Biopharmaceutical, Immunotherapy, Autoimmune, Oncology, Clinical Stage, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/barinthus-biotherapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.